The Valley Desk

NCT05559359 · Interventional trial

A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis

Overall registry status Active not recruiting

Phase 3

Conditions Atopic Dermatitis, Eczema

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov